Abbott's Earnings: A Miss, Medical Device Growth, and China
Update: 2025-10-15
Description
Abbott's Q3 earnings stumble! A slight revenue miss, driven by slumping diagnostics and nutrition sales due to decreased COVID-19 test demand, U.S. tariffs, and foreign aid halts, sent shares tumbling. While medical device sales surged, fueled by heart devices and glucose monitors, it wasn't enough to offset the losses. Pressure from China's bulk buying and potential new tariffs add to the uncertainty, but Abbott maintains its annual profit forecast, banking on its strong sectors to weather the storm.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
